Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I
Steven C. Campbell, Peter E. Clark, Sam S. Chang, et al.
The Journal of Urology (2021) Vol. 206, Iss. 2, pp. 199-208
Open Access | Times Cited: 467

Showing 1-25 of 467 citing articles:

Treatment Landscape of Renal Cell Carcinoma
Yu‐Wei Chen, Luke Wang, Justine Panian, et al.
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 12, pp. 1889-1916
Open Access | Times Cited: 43
Renal Cell Carcinoma
Tracy L. Rose, William Y. Kim
JAMA (2024) Vol. 332, Iss. 12, pp. 1001-1001
Closed Access | Times Cited: 33
Outcomes and Techniques of Robotic-Assisted Partial Nephrectomy (RAPN) for Renal Hilar Masses: A Comprehensive Systematic Review
Savio Domenico Pandolfo, Zhenjie Wu, Riccardo Campi, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 693-693
Open Access | Times Cited: 32
[89Zr]Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial
Brian Shuch, Allan J. Pantuck, Jean‐Christophe Bernhard, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 10, pp. 1277-1287
Open Access | Times Cited: 28
Comparative efficacy and safety of ablative therapies in the management of primary localised renal cell carcinoma: a systematic review and meta-analysis
Ryan S. Huang, Ronald Chow, Ali Benour, et al.
The Lancet Oncology (2025)
Closed Access | Times Cited: 6
Results of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma in a Large Multicenter Series
Ludwige Abancourt, Muhammad Ali, Magali Quivrin, et al.
European Urology Oncology (2025)
Closed Access | Times Cited: 2
Percutaneous Cryotherapy and Radiofrequency Ablation of Renal Masses: Multicenter Comparative Analysis with Minimum 3-Year Follow-up
Umberto Carbonara, Francesco Ditonno, Alp Tuna Beksaç, et al.
International braz j urol (2025) Vol. 51, Iss. 2
Open Access | Times Cited: 2
How We Do It: Managing the Indeterminate Renal Mass with the MRI Clear Cell Likelihood Score
Iván Pedrosa, Jeffrey A. Cadeddu
Radiology (2021) Vol. 302, Iss. 2, pp. 256-269
Open Access | Times Cited: 57
A systematic review of robot-assisted partial nephrectomy outcomes for advanced indications: Large tumors (cT2-T3), solitary kidney, completely endophytic, hilar, recurrent, and multiple renal tumors
Savio Domenico Pandolfo, Clara Cerrato, Zhenjie Wu, et al.
Asian journal of urology (2023) Vol. 10, Iss. 4, pp. 390-406
Open Access | Times Cited: 34
Partial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group
Clara Cerrato, Devin Patel, Riccardo Autorino, et al.
World Journal of Urology (2023) Vol. 41, Iss. 3, pp. 747-755
Closed Access | Times Cited: 31
Estimating Postoperative Renal Function After Surgery for Nonmetastatic Renal Masses: A Systematic Review of Available Prediction Models
Alessio Pecoraro, Riccardo Campi, Riccardo Bertolo, et al.
European Urology Oncology (2023) Vol. 6, Iss. 2, pp. 137-147
Open Access | Times Cited: 24
Enhanced Artificial Intelligence Strategies in Renal Oncology: Iterative Optimization and Comparative Analysis of GPT 3.5 Versus 4.0
Rui Liang, Anguo Zhao, Peng Lei, et al.
Annals of Surgical Oncology (2024) Vol. 31, Iss. 6, pp. 3887-3893
Closed Access | Times Cited: 15
The evolving management of small renal masses
Yuzhi Wang, Mohit Butaney, Samantha Wilder, et al.
Nature Reviews Urology (2024) Vol. 21, Iss. 7, pp. 406-421
Closed Access | Times Cited: 9
Partial Nephrectomy Versus Tumor Ablation for T1 Renal Cell Carcinoma: Equally Effective?
Anna M. Zeelenberg, G.H. KleinJan, R.W. van der Meer, et al.
JU Open Plus (2025) Vol. 3, Iss. 1
Closed Access | Times Cited: 1
Partial nephrectomy for a completely endophytic tumor in an allograft kidney, 14 years after transplantation
Vivek Dadasaheb Patil, Prashanth Reddy Yensani, V. Krishna Prasad, et al.
Indian Journal of Urology (2025)
Open Access | Times Cited: 1
Editorial comment on “Tailoring Renal Mass Biopsy: Optimal Core Number and Location Based on Tumor Size for Enhanced Diagnostic Accuracy- A Prospective Ex-Vivo Study”
Patrick Michael, Rebecca A. Campbell
Urology (2025)
Closed Access | Times Cited: 1
Current use of percutaneous ablation in renal tumors: an analysis of the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy
Benedikt M. Schaarschmidt, Sebastian Zensen, Claudia Kesch, et al.
European Radiology (2025) Vol. 35, Iss. 3, pp. 1723-1731
Open Access | Times Cited: 1
Renal parenchymal volume analysis: Clinical and research applications
Carlos Muñoz-López, Kieran Lewis, Nityam Rathi, et al.
BJUI Compass (2025) Vol. 6, Iss. 3
Open Access | Times Cited: 1
Frailty index and nutrition status impact perioperative outcomes in patients undergoing minimally invasive radical nephrectomy
David E. Hinojosa-González, Gal Saffati, Gustavo Salgado‐Garza, et al.
Journal of Robotic Surgery (2025) Vol. 19, Iss. 1
Closed Access | Times Cited: 1
Percutaneous Ablation vs Robot-Assisted Partial Nephrectomy for Completely Endophytic Renal Masses: A Multicenter Trifecta Analysis with a Minimum 3-Year Follow-Up
Savio Domenico Pandolfo, Alp Tuna Beksaç, Ithaar Derweesh, et al.
Journal of Endourology (2022) Vol. 37, Iss. 3, pp. 279-285
Closed Access | Times Cited: 34
Percutaneous thermal ablation for cT1 renal mass in solitary kidney: A multicenter trifecta comparative analysis versus robot-assisted partial nephrectomy
Savio Domenico Pandolfo, Davide Loizzo, Alp Tuna Beksaç, et al.
European Journal of Surgical Oncology (2022) Vol. 49, Iss. 2, pp. 486-490
Closed Access | Times Cited: 33
Deep learning and radiomic feature-based blending ensemble classifier for malignancy risk prediction in cystic renal lesions
Quan-Hao He, Jia-Jun Feng, Fajin Lv, et al.
Insights into Imaging (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Transperitoneal Versus Retroperitoneal Single-port Robotic-assisted Partial Nephrectomy: An Analysis from the Single Port Advanced Research Consortium
Jordan Rich, Kennedy E. Okhawere, Charles Nguyen, et al.
European Urology Focus (2023) Vol. 9, Iss. 6, pp. 1059-1064
Closed Access | Times Cited: 18
Novel VEGFR‐2 Kinase Inhibitors as Anticancer Agents: A Review Focusing on SAR and Molecular Docking Studies (2016–2021)
S. Vishakha, Kumari Kajal, Sitanshu Mondal, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 2
Closed Access | Times Cited: 17
The emerging landscape of neo/adjuvant immunotherapy in renal cell carcinoma
Pooya Dibajnia, Luisa M. Cardenas, Aly‐Khan A. Lalani
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top